Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma

Keyphrases

• Airway Hyperresponsiveness 25%
• Allergic Airway 12%
• Allergic Airway Disease 12%
• Allergic Airway Inflammation 100%
• Allergic Asthma 12%
• Allergic Diseases 12%
• Allergic Inflammation 12%
• Allergic Reaction 12%
• Anti-inflammatory Activity 12%
• Bone Marrow-derived Dendritic Cells 100%
• Bronchoalveolar Lavage Fluid 12%
• CCR7 12%
• CD4+ T 12%
• CD80 12%
• CD86 12%
• Cell Surface Markers 12%
• Cytokine Production 12%
• Dendritic Cell Maturation 12%
• Eotaxin 12%
• Interleukin-13 (IL-13) 25%
• Interleukin-4 (IL-4) 37%
• Interleukin-5 (IL-5) 37%
• Intratracheal Instillation 12%
• Lung Airways 12%
• Lung Cells 12%
• Lung Eosinophilia 12%
• Lymph Node Cells 12%
• Lymphocytes 12%
• Mediastinal Lymph Nodes 12%
• MHC Class II 12%
• Mouse Model of Asthma 100%
• Murine Bone Marrow 25%
• Ovalbumin 62%
• OX40 12%
• Screening Drugs 12%
• Shikonin 100%
• T Cell Proliferation 12%
• T Cells 12%
• T-cell Cytokines 12%
• Therapeutic Potential 12%
• Thymic Stromal Lymphopoietin 25%
• Tumor Necrosis Factor-α 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Allergic Airway Inflammation 100%
• Allergic Asthma 12%
• Allergic Reaction 12%
• Anti-Inflammatory Drug 12%
• Asthma 100%
• Cell Surface Marker 12%
• Cytokine 12%
• Diseases 12%
• Drug Screening 12%
• Eotaxin 12%
• Inflammation 12%
• Interleukin 13 25%
• Interleukin 4 37%
• Interleukin 5 37%
• Ovalbumin 62%
• Respiratory Tract Allergy 25%
• Respiratory Tract Disease 12%
• Shikonin 100%
• Thymic Stromal Lymphopoietin 25%
• Tumor Necrosis 25%